HR 5969 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
To amend the Federal Food, Drug, and Cosmetic Act to ensure that abortion-inducing drugs bear a label identifying the name and address of the dispenser and the name of the prescriber, and for other purposes.
Summary
The bill amends the Federal Food, Drug, and Cosmetic Act to require that abortion-inducing drugs bear labels identifying the name and address of the dispenser and the name of the prescriber. Drugs that do not include this information on the label are deemed misbranded under Federal law. The bill also prohibits states or political subdivisions from establishing less stringent labeling requirements than those in the bill.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
- Rep. Moore, Barry [R-AL-1] (R-AL)
15 cosponsors
- Rep. Biggs, Sheri [R-SC-3] (R-SC)
- Rep. Bost, Mike [R-IL-12] (R-IL)
- Rep. Burchett, Tim [R-TN-2] (R-TN)
- Rep. Clyde, Andrew S. [R-GA-9] (R-GA)
- Rep. Estes, Ron [R-KS-4] (R-KS)
- Rep. Guest, Michael [R-MS-3] (R-MS)
- Rep. Hageman, Harriet M. [R-WY-At Large] (R-WY)
- Rep. Harrigan, Pat [R-NC-10] (R-NC)
- Rep. Harris, Andy [R-MD-1] (R-MD)
- Rep. Harris, Mark [R-NC-8] (R-NC)
- Rep. McGuire, John J. [R-VA-5] (R-VA)
- Rep. Miller, Mary E. [R-IL-15] (R-IL)
- Rep. Palmer, Gary J. [R-AL-6] (R-AL)
- Rep. Pfluger, August [R-TX-11] (R-TX)
- Rep. Steube, W. Gregory [R-FL-17] (R-FL)
Actions (2)
- Nov 7, 2025 Referred to the House Committee on Energy and Commerce. · house
- Nov 7, 2025 Introduced in House
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Full text
IN THE HOUSE OF REPRESENTATIVES
November 7, 2025
Mr. Moore of Alabama (for himself, Ms. Hageman, Mrs. Miller of Illinois, Mr. McGuire, Mr. Harris of Maryland, Mr. Palmer, Mr. Clyde, and Mr. Pfluger) introduced the following bill; which was referred to the Committee on Energy and Commerce
A BILL
To amend the Federal Food, Drug, and Cosmetic Act to ensure that abortion-inducing drugs bear a label identifying the name and address of the dispenser and the name of the prescriber, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Linking Abortion-drug Batches for Enforcement and Liability Act” or the “LABEL Act”.
SEC. 2. LABELING REQUIREMENTS FOR ABORTION-INDUCING DRUGS.
(a) In General.—Section 503(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353(b)) is amended by adding at the end the following:
“(6)(A) Notwithstanding any other provision of this Act, in the case of an abortion-inducing drug, the drug shall be deemed to be misbranded unless the drug bears a label that identifies—
“(i) the name and address of the dispenser; and
“(ii) the name of the prescriber.
“(B) No State or political subdivision of a State may establish, continue in effect, or enforce a labeling requirement for an abortion- inducing drug that is not at least as stringent as the labeling requirement in subparagraph (A).
“(C) In this paragraph, the term ‘abortion-inducing drug’—
“(i) means a drug that is intended, alone or in combination with 1 or more other drugs, for use or that is in fact used (irrespective of how the drug is labeled) to kill the unborn child of a woman known to be pregnant or to terminate the pregnancy of a woman known to be pregnant; but
“(ii) does not include a drug that is intended, alone or in combination with 1 or more other drugs, for use to remove a dead unborn child of a woman known to be pregnant or to treat an ectopic pregnancy.”.
(b) Severability.—If any provision of this section, the amendment made by this section, or the application of such provision or amendment to any person or circumstance is held to be unconstitutional, the remainder of this section, the amendment made by this section, and the application of the provision to such person or circumstance shall not be affected thereby. <all>
Comments